We have formed an organization for the development of new drugs using professional knowledge such as research and clinical experience accumulated over the years to replace much of the unmet needs without inequality for economic reasons.

Established in 2016 with abundant clinical experience in the field of ophthalmology, EYEBIOKOREA is a Bio company that focuses its research capabilities by specializing in the field of ophthalmological diseases based on innovative and progressive R&D from start-up ideology to its current vision.We have various ophthalmic pipelines such as age-related macular degeneration, diabetic retinopathy, dry eye disease, and thyroid eye disease, and continuously investing in innovative technologies through cooperation with various research institutes and pharmaceutical companies.

EYEBIOKOREA promises to continue to grow as a company that contributes to the improvement of human health and quality of life, considering the nobility of human beings and the value of life as the top priority.